Embed Size (px)
Citation preview
www.baltic18.org
Programme
BALTIC185th Baltic Meeting in conjunction with the EAU
25-26 May 2018, Riga, Latvia
AbstractsThe presented abstracts of the 5th Baltic meeting are going to be published online by Elsevier as an official supplement of European Urology. These e-abstracts will be online as of 1 July 2018 at www.europeanurology.com. The abstracts will also be online at https://baltic.uroweb.org/. The abstracts are documented in an international online journal and can be cited, providing proof of the academic productivity of the regions.
AccreditationThe 5th Baltic Meeting in conjunction with the EAU is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.
The 5th Baltic Meeting in conjunction with the EAU is designated for a maximum of 11 hours of European external CME credits. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.
Certificate of attendanceDelegates who have attended the meeting can print their certificate of attendance onlinethrough https://baltic.uroweb.org/ using the barcode on the badge. This option is available as of Wednesday, 30 May 2018.
ExhibitionThe local organising committee has invited pharmaceutical companies, manufacturers oftechnical equipment and software as well as publishers of scientific books to exhibit theirproducts at the exhibition organised at the meeting venue.
General Information
2 5th Baltic meeting in conjunction with the EAU
08.45 - 09.00 Welcome P. Vaganovs, Riga (LV) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY) C.R. Chapple, Sheffield (GB) J.O.R. Sonksen, Herlev (DK)
09.00 - 09.30 EAU Lecture Where are we in male infertility in 2018? J.O.R. Sonksen, Herlev (DK)
09.30 - 10.30 Session 1 Advances in imaging radiotherapy on prostate cancer Chairs: M. Kivi, Tallinn (EE) E. Vjaters, Riga (LV)
09.30 - 09.45 Evaluation of multiparametric prostate MRI M. Žarkovski, Tartu (EE)09.45 - 10.00 The role of robotic radiosurgery in treatment of solitary and oligometastatic
relapses of prostate cancer M. Mezeckis, Sigulda (LV) 10.00 - 10.15 Low-dose rate and high-dose rate brachytherapy in prostate cancer R.A. Lenkaityte, Vilnius (LT)10.15 - 10.30 Use of PSMA PET-CT in biochemical relapse of prostate cancer M. Kalnina, Riga (LV)
10.30 - 11.00 Coffee break
11.00 - 12.00 Young Urologists Competition Chairs: T. Murtola, Kangasala (FI) J. Vasquez, Copenhagen (DK)
Judges: C.R. Chapple, Sheffield (GB) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) J.O.R. Sonksen, Herlev (DK) A. Strotsky, Minsk (BY) P. Vaganovs, Riga (LV)
11.00 - 11.15 Prostate Cancer Screening: Current status and future perspectives S. Semenov, Minsk (BY)11.15 - 11.30 The role of gene polymorphisms in female urinary incontinence P. Aniulis, Kaunas (LT)
Programme Friday, 25 May 2018
325-26 May 2018
Programme Friday, 25 May 2018
11.30 - 11.45 Multidisciplinary management of blunt kidney trauma K. Miculis, Riga (LV)11.45 - 12.00 Upper Tract Urothelial Carcinoma: Is it possible to save the kidney? T. Põdramägi, Tartu (EE)
12.00 - 13.00 Industry sponsored session See programme page 16
13.00 - 14.00 Lunch and poster viewing
14.00 - 15.15 Poster session 1: Prostate cancer - screening, detection and surveillance Room: Beta 1 Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK)
14.00 - 15.15 Poster session 2: Voiding dysfunction, andrology and miscellaneous Room: Beta 2 Chairs: C.R. Chapple, Sheffield (GB) A. Strotsky, Minsk (BY)
15.15 - 16.15 Session 2 Urinary tract infections Chairs: C.R. Chapple, Sheffield (GB) J. Kahu, Tartu (EE)
15.15 - 15.30 Possibilities and challenges in treatment of recurrent UTI D. Nitkin, Minsk (BY) 15.30 - 15.45 Influences on microbiome - quo vadis? A. Gessner, Regensburg (DE) 15.45 - 16.00 Perioperative antibacterial prophylaxis U. Dumpis, Riga (LV) 16.00 - 16.15 Discussion
16.15 - 16.30 Coffee break and poster viewing
16.30 - 17.45 Poster session 3: Renal cancer and treatment of prostate cancer Room: Beta 1 Chairs: M. Jievaltas, Vilnius (LT) T. Murtola, Kangasala (FI)
16.30 - 17.45 Poster session 4: Adrenals and stones Room: Beta 2 Chairs: P. Vaganovs, Riga (LV) J.L. Vasquez, Copenhagen (DK)
4 5th Baltic meeting in conjunction with the EAU
Programme Friday, 25 May 2018
ESU/ ESUT Hands-on Training in laparoscopy
Course Coordinator: P. Macek, Prague (CZ)
Format: Introduction by course coordinator (5 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (5 minutes)
Room: Gamma
09.00 - 10.30 Course 1 Chair: P. Macek, Prague (CZ) Tutors: C.S. Biyani, Leeds (GB) P. Macek, Prague (CZ) T. Muul, Tartu (EE)
14.00 - 15.30 Course 2 Chair: P. Macek, Prague (CZ) Tutors: C.S. Biyani, Leeds (GB) P. Bosas, Kaunas (LT) P. Macek, Prague (CZ)
16.30 - 17.30 Course 1: Case discussions, Tips & Tricks and Experience exchange Tutors: C.S. Biyani, Leeds (GB) P. Macek, Prague (CZ)
This course will focus on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. Nephrectomy) and how to manage this situation.
The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course.
Aims and objectivesLaparoscopic procedures are continuously evolving in urology based on the increasing expertise of urologic surgeons. This includes ablative procedures, such as radical nephrectomy as well as reconstructive techniques, such as pyeloplasty. Some advanced procedures (i.e. radical prostatectomy, radical cystectomy) have both, ablative and reconstructive steps. Since the number of centres with laparoscopic expertise is still limited in Europe, laparoscopic training programmes have become very important. Hands-on training courses at the pelvi-trainer represent one of the ain steps of such courses. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.
525-26 May 2018
Programme Saturday, 26 May 2018
08.30 - 09.30 State-of-the-art lecture Prostate cancer Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK)
08.30 - 09.15 Update on prostate cancer N. Mottet, Saint-Étienne (FR) 09.15 - 09.30 Discussion
09.30 - 09.45 Coffee break
09.45 - 10.45 Industry sponsored session See programme page 17
10.45 - 13.15 ESU Course Bladder cancer Chair: J. Palou, Barcelona (ES)
10.45 - 10.50 European School of Urology: A unique possibility for urological education J. Palou, Barcelona (ES)10.50 - 11.05 EAU Guidelines recommendations on bladder cancer J. Palou, Barcelona (ES)11.05 - 11.30 Urinary markers in bladder cancer: The future? E. Xylinas, Paris (FR) 11.30 - 11.50 TURBT, Re-TURBT, En bloc resection: Where are we? J. Palou, Barcelona (ES)11.50 - 12.10 Let s improve the management of patients in radical cystectomy E. Xylinas, Paris (FR)12.10 - 12.25 Chemotherapy, Immunotherapy or what in metastatic bladder cancer? J. Palou, Barcelona (ES)12.25 - 13.15 Interactive case discussion ESU faculty M. Meniss, Riga (LV) M. Mikkal, Tartu (EE)
13.15 - 14.15 Lunch and poster viewing
6 5th Baltic meeting in conjunction with the EAU
Programme Saturday, 26 May 2018
14.15 - 15.30 Poster session 5: Urothelial tumours and BPO Room: Beta 1 Chairs: A. Minich, Minsk (BY) TBC
14.15 - 15.30 Poster session 6: Infections and paediatrics Room: Beta 2 Chairs: V. Lietuvietis, Riga (LV) TBC
15.30 - 16.30 Session 3 Video session Chairs: M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE)
15.30 - 15.45 3D possibilities in laparoscopic surgery E. Vjaters, Riga (LV)15.45 - 16.00 Laser en bloc resection of bladder tumour D. Tarend, Minsk (BY)16.00 - 16.15 Laparoscopic surgery: transvaginal NOTES-assisted laparoscopic
nephroureterectomy P. Bosas, Vilnius (LT)16.15 - 16.30 Laparoscopic removal of large adrenal gland tumour R. Ots, Tartu (EE)
16.30 - 16.45 Awards for Best Poster Presentation and Young Urologist Competition P. Vaganovs, Riga (LV)
16.45 - 17.00 Closing remarks and farewell P. Vaganovs, Riga (LV) M. Jievaltas, Kaunas (LT) A. Kotsar, Tartu (EE) A. Strotsky, Minsk (BY)
725-26 May 2018
Programme Saturday, 26 May 2018
ESU/ ESUT Hands-on training in Ureterorenoscopy
Course Coordinator: A. Ploumidis, Athens (GR)
Format: Introduction by course coordinator (15 minutes) Hands-on-training at different models (80 minutes) Questions and answers, tips and tricks (25 minutes)
Room: Gamma
08.30 - 10.30 Course 1 Chair: A. Ploumidis, Athens (GR) Tutors: C.S. Biyani, Leeds (GB) I. Geldners, Riga (LV) A. Ploumidis, Athens (GR)
11.00 - 13.00 Course 2 Chair: A. Ploumidis, Athens (GR) Tutors: C.S. Biyani, Leeds (GB) R. Ots, Tartu (EE) A. Ploumidis, Athens (GR)
14.00 - 15.00 Course 2: Case discussions, Tips & Tricks and Experience exchange Tutors: C.S. Biyani, Leeds (GB) A. Ploumidis, Athens (GR)
This course will focus on the technical aspects of interesting clinical cases. Two expert surgeons discuss 1-2 prepared cases, each that show a difficult situation that occurs during surgery (e.g. management of bleeding of the renal pedicle during lap. Nephrectomy) and how to manage this situation.
The cases are prepared by the tutors of the course and discussed with the participants of the course in an interactive way. Furthermore special tips & tricks are shown and/or discussed by the tutors. This leads to an experience exchange that is beneficial for every participant of the course.
Aims and objectivesThe European Society of Uro-Technology (ESUT) and the EAU Section of Urolithiasis (EULIS) offer an intensive hands-on training course with different models focussing on the endoscopic management of urolithiasis. The delegates will be taken through a sequential programme of Ureterorenoscopy using normal endoscopic instruments in different models. The use of various guide-wires, baskets and intracorporeal lithotripters will be demonstrated. The ESUT and the EULIS faculty consist of experienced surgeons in the field of Ureterorenoscopy. A video demonstrating the different steps and tasks of the procedures will be presented and afterwards the delegates will be instructed according to their level of experience in small teams at the models. Finally, all remaining questions can be answered and discussed with all tutors including the demonstration of tips and tricks.
8 5th Baltic meeting in conjunction with the EAU
Poster session 1
Friday, 25 May 2018
14.00 - 15.15 Prostate cancer - screening, detection and surveillance Chairs: F. Jankevicius, Vilnius (LT) J.O.R. Sonksen, Herlev (DK)Beta Room 1
1 Multiple cancers among prostate cancer patients diagnosed in Estonia 1995-2015Kase M., Ojamaa K., Vardja M., Kase S., Zahharova I., Jaal J., Jaal J. (Tallinn,Tartu, Estonia; Riga, Latvia)
2 Association between ABO blood groups and aggressiveness of prostate cancerBhuvanagiri A.K., Kannan S, Williams W.S.M, Gundupalli D., Fegredo D., Hassan U., Allen B., Robinson B., Arshad S., Nadeem T., Edge E., Tivey A., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom)
3 Does PSA-based population screening increase suicide risk in prostate cancer patients? National experience from Lithuania early detection programmePatasius A., Kaceniene A., Ulys A., Smailyte G. (Vilnius, Lithuania)
4 Divergent Maspin expression in benign and malignant basal cell lesions in the prostateOtzetov A.G., T. Sitaram R., Mallikajuna P., Wanders A. (Umeå, Sweden)
5 Association of body mass index, PSA, prostate volume and prostate cancerBhuvanagiri A.K., Kannan S., Gundupalli D., Fegredo D., Nadeem T., Tivey A., Edge E., Allen B., Robinson B., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom)
6 Diagnostic accuracy of [-2]proPSA, %p2PSA and Prostate Health Index for prostate cancer detectionBarisiene M., Stanciute D., Bakavicius A., Jurkeviciene J., Zelvys A., Ulys A., Jankevicius F. (Vilnius, Lithuania)
7 What should be the PSA threshold value in patients with PSA elevation without digital rectal examination findings? 2,5 or 4 ng/mL?Ediz C., Yilmaz Ö., Koksal O., Akan S., Ates F., Cakmak S., Temel M.C., Hayit H., Sariogullari U. (Istanbul, Turkey)
8 Early detection of prostate cancer in men aged 45-55 with PSA level 2.5-4.0 ng/mlSemenov S., Krasny S., Minich A. (Minsk, Belarus)
9 The diagnostic value of PSA density in predicting prostate biopsy outcomesMaris N., Kotsar A., Žarkovski M., Värk P., Punab M. (Tartu, Estonia)
10 Pathological correlation between needle biopsy and radical prostatectomy specimen in patients with localized prostate cancer G1Sperga G., Jakubovskis M., Sperga M., Redmanis L., Lietuvietis V. (Riga, Latvia)
11 Repeated 24-core systematic and targeted biopsy in detection of clinically significant prostate cancerKarman A.V., Shimanets S.V., Minich A.A., Rolevich A.I., Karman T.A., Krasny S.A. (Minsk, Belarus)
12 Multiparametric MRI targeted and transrectal ultrasound guided transperineal prostate biopsy in men with previous negative prostate biopsyKivi M., Nelzin D., Kõdar K., Semjonov E. (Tallinn, Estonia)
13 PET CT [18F] - labelled choline imaging in primary assessment of prostate cancer: Is it helpful in local staging?Witek M., Klonowski P., Jaskulski J., Orlowski P., Obarzanowski M. (Kielce, Poland)
14 mpMagnetic Resonance Imaging accuracy in the detection of localized prostate cancerNarcisko V.F, Baumanis E., Lietuvietis V., Strazdina A. (Riga, Latvia)
15 Epigenetic markers to overcome limitations in prostate cancer diagnosticsBakavicius A., Daniunaite K., Jarmalaite S., Jankevicius F. (Vilnius, Lithuania)
16 Evaluation of patients with greater risk of prostate cancer progression in active surveillance after second biopsyMickevicius L., Mickevicius R., Jievaltas M. (Kaunas, Lithuania)
17 Low risk prostate cancer - active surveillance outcomesEdiz C., Yilmaz Ö., Ates F., Akan S., Sariogullari U., Cakmak S., Temel M.C., Hayit H. (Istanbul, Turkey)
925-26 May 2018
Poster session 2
Friday, 25 May 2018
14.00 - 15.15 Voiding dysfunction, andrology and miscellaneous Chairs: C.R. Chapple, Sheffield (GB) A. Strotsky, Minsk (BY)Beta Room 2
18 Does inguinal hernia repair affect uroflowmetric parameters? A prospective controlled clinical trialUnal Y., Kilinc M.F. (Ankara, Turkey)
19 The influence of specific urinary incontinence type on the quality of life of incontinent womenVolotovska J., Dr. Pilsetniece Z., Prof. Vjaters E. (Riga, Latvia)
20 Patient history, physical and urodynamic data role in diagnostic of specific type of urinary incontinence in femalePilsetniece Z., Vjaters E. (Riga, Latvia)
21 Efficacy of suburethral sling for the treatment of female stress urinary incontinenceChaker K., Sellami A., Ben Chehida M.A., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
22 Effectiveness of different postoperative training programs on pelvic floor muscles strengthening and reducing of urinary incontinence in men after radical prostatectomy: Results of randomized controlled clinical trialMilonas D., Siupsinskas L., Zachovajevas P., Zachovajieviene B. (Kaunas, Lithuania)
23 Tamsulosin can improve lower urinary tract symptoms in patients under active surveillance due to low risk prostate cancerDalkilic A., Bayar G., Kilinc M.F., Yavuz A., Tanriverdi O., Horasanli K. (Istanbul,Ankara,Hatay, Turkey)
24 Treatment of dysuric disorders in patients with urinary bladder leukoplakiaRahuzin A., Strotsky A., Obrazkov K. (Minsk, Belarus)
25 The effect of hyperbaric oxygen therapy on erectile functions: A prospective clinical studySahin M.O., Sen V., Eser E., Koc E., Gumus U., Karakuzu C., Ucer O. (Manisa,Izmir, Turkey)
26 Ultrasound examination internal genital artery transperineal access when arteriogenic erectile dysfunctionPovelitsa E. (Gomel, Belarus)
27 Self-treatment methods of patients diagnosed with premature ejaculation before admissionCimen S. (Malatya, Turkey)
28 Etiological factors and management of priapismChaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
29 Approach to managing penile fractures at a secondary state hospitalCimen S. (Malatya, Turkey)
30 Which factors affect the success of iatrogenic obstetric vesical fistulas?Kati B., Ciftci H., Pelit E.S., Yagmur I., Ordek E. (Sanliurfa, Turkey)
31 Prognostic factors of laparoscopic Anderson-Hynes pyeloplasty in treatment of ureteropelvic junction obstruction: A pilot studyCekauskas A., Jakubauskas M., Bielinis A., Vajauskas D., Zelvys A. (Vilnius, Lithuania)
32 Intraurethral erythropoietin to prevent fibrosis and improve urethral healing: An experimental study in a rat modelKilinc M.F., Doluoglu O.G., Eser E.P., Yildiz Y., Yazar V.M., Ayyildiz A., Hucumenoglu S. (Ankara, Turkey)
33 Ureteral stricture relapse risk factors after endoureterotomyChernysheva D., Popov S.V., Orlov I.N., Vyazovtsev P.V. (Saint-Petersburg, Russia)
V1 Laparoscopic pyeloplasty combined with flexible nephroscopyCerskute M., Cekauskas A., Januskevicius T., Tyla R., Zelvys A. (Vilnius, Lithuania)
10 5th Baltic meeting in conjunction with the EAU
Poster session 3
Friday, 25 May 2018
16.30 - 17.45 Renal cancer and treatment of prostate cancer Chairs: M. Jievaltas, Kauno Rajonas (LT) T. Murtola, Kangasala (FI)Beta Room 1
34 Renal cancer incidence, mortality and survival trends in Estonia, 1995-2014Sepp T., Kotsar A., Lang K., Innos K. (Tartu, Tartu,Tallinn, Estonia)
35 DNA methylation profile of cear cell renal carcinomaKubiliute R., Žalimas A., Ulys A., Jankevicius F., Jarmalaite S. (Vilnius, Lithuania)
36 Tumors of native kidneys in dialysed and in renal transplant patientsCekas K., Ramonas H. (Vilnius, Lithuania)
37 Role of nephrometric scores in the prediction of warm ischemia time and the renal function outcomes in patients who underwent nephron-sparing surgery for renal cancerChaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
38 Predictors of renal parenchymal volume loss after partial nephrectomyAtalay H.A., Özbir S. (Istanbul, Turkey)
39 Surgery for metastases of renal cell carcinoma: Outcome of treatments and external assessment of Leuven-Udine prognostic groupsErkkilä K., Visapää H., Kilpeläinen T., Taari K., Järvinen R., Tornberg S., Nisen H., Järvinen P. (Helsinki, Finland)
40 Retroperitoneal and transperitoneal laparoscopic cryoablation of small renal tumours - follow up studyKailasa A.K., Rogers M., Khan I. (Scunthorpe, United Kingdom)
41 Impact of the metabolic syndrome on the renal function after partial nephrectomy for non metastatic localized renal cell carcinomaChaker K., Ben Rhouma S., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Nouira Y. (Tunis, Tunisia)
42 Renal function outcomes after partial nephrectomy and radical nephrectomy for small renal cancer: A comparative studyChaker K., Sellami A., Ouanes Y., Bibi M., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
43 Overall survival in patients underwent open partial nephrectomy in a solitary kidneySuslov L., Sukonko O., Polyakov S., Krasny S., Mirilenko L. (Minsk, Belarus)
44 Quality of life after medical versus surgical castration for locally advanced or metastatic prostate cancerChaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
45 Long-term outcome of localized prostate cancer treated with brachytherapyVaiciunas K., Babakinas J., Jokubonis K., Jarusevicius L., Inciura A., Juozaityte E., Jievaltas M. (Kaunas, Lithuania)
46 4 years outcome in 143 patients receiving low-dose I125 brachytherapyPurvaneckas J., Makevicius J., Rimas A., Sniureviciute M. (Vilnius, Lithuania)
47 Influence of number of core with adenocarcinoma on Gleason score upgrade in patients undergoing radical prostatectomyEdiz C., Akan S., Cakmak S., Ates F., Yilmaz O., Temel M.C., Koksal O., Hayit H., Sariogullari U. (Istanbul, Turkey)
48 Effectiveness of salvage pelvic surgery for clinically recurrent prostate cancer after initial curative treatment: First experience of single tertiary centerDomarkas A., Auskalnis S., Jievaltas M., Milonas D. (Kaunas, Lithuania)
49 Do the pelvic irradiation and adjuvant androgen-deprivation therapy improve efficacy of salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy?Polyakov S., Semenov S., Demeshko P., Krasny S. (Minsk, Belarus)
50 Metastasis-free and cancer-specific survival after salvage radiotherapy in patients with biochemical recurrence treated with radical prostatectomyPolyakov S., Krasny S., Demeshko P., Semenov S., Minich A. (Minsk, Belarus)
51 Blood-circulating androgen receptor variants as markers for progression and response to treatment in prostate cancer patientsStuopelyte K., Sestokaite A., Haflidadottir B.S., Visakorpi T., Ulys A., Jankevicius F., Jarmalaite S. (Vilnius, Lithuania; Tampere, Finland)
52 The importance of immediate prostate specific antigen value after radical prostatectomy on prediction of clinical progression in lymph node positive patientsAstrauskas M., Cepas G., Jievaltas M., Milonas D. (Kaunas, Lithuania)
53 Prognostic significance of time until biochemical recurrence on clinical progression in surgically treated high-risk prostate cancer patientsVenclovas Z., Auskalnis S., Jievaltas M., Milonas D. (Kaunas, Lithuania)
54 68Ga-PSMA ligand PET/CT in patients with biochemical recurrence after prostate cancer treatment - initial dataFreimanis A., Lietuvietis V., Vjaters E., Roznere L., Zemniece L., Kalnina M., Tirane M., Radzina M. (Riga, Latvia)
55 The effect of lymphadenectomy extent on early postoperative undetectable PSA rate among prostate cancer pT3b R0 patients at West-Tallinn Central HospitalOkas R., Alas I. (Tallinn, Estonia)
1125-26 May 2018
Poster session 4
Friday, 25 May 2018
16.30 - 17.45 Adrenals and stones Chairs: P. Vaganovs, Riga (LV) J.L. Vásquez, Copenhagen (DK)Beta Room 2
56 Adrenal ganglioneuroma: A case reportKivi M., Ahlberg A., Kalju K., Kõdar K. (Tallinn, Estonia)
V2 Laparoscopic left adrenalectomy. Adrenal ganglioneuromaKivi M., Ahlberg A., Põdramägi T., Dmitrijeva N., Levin D. (Tallinn, Estonia)
57 Analysis of the impact on complications of remaining in the surgical waiting list for endoscopic treatment of ureteral stonesPurvaneckas J., Želvys A. (Vilnius, Lithuania)
58 Association between haematuria and urinary tract calculiBhuvanagiri A.K., Kannan S., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Edge E., Tivey A., William S.M.W., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom)
59 White cell count, C-reactive protein and serum creatinine as indicators for stent insertions in urinary tract stonesKannan S., Bhuvanagiri A., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Edge E., Tivey A., Thangavelu M., Ahiaku E., Alexandrou K. (Bangor, United Kingdom)
60 A new approach to the dietary stereotypes study in urolithiasis patientsAnokhin N.A., Prosiannikov M.Y., Shaderkin I.A., Konstantinova O.V., Golovanov S.A., Zelenskiy M.M., Voytko D.A., Apolihin O.I., Sivkov A.V. (Moscow, Russia)
61 Distinguishing of impacted ureteral stones by using Hounsfield unitsÖzbir S., Atalay H.A. (Istanbul, Turkey)
62 Percutaneous nephrolithotomy for staghorn stonesChaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
63 Evaluation of endoscopic treatment of complicated ureterocele in adultsChaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
64 Treatment modalities and its impact on the management of SteinstrasseChaker K., Sellami A., Ben Chehida M.A., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
65 Endoscopic combined intrarenal surgery value in multiple renal stones treatmentKavaliauskaite R., Želvys A. (Vilnius, Lithuania)
66 A prospective, randomized comparison of retrograde intrarenal surgery and percutaneous nephrolithotomy for treatment of 1 to 2 cm lower calyceal renal stonesBayar G., Kilinc M.F., Yavuz A., Yazar V.M., Cakmak S. (Istanbul,Ankara,Hatay, Turkey)
67 The influence of stone burden and its ratio to renal collecting system volume on complication rates of percutaneous nephrolithotomyÖzbir S., Atalay H.A. (Istanbul, Turkey)
68 The effect of perirenal fat stranding on infection related complications after ureterorenoscopy in patients with ureteral calculiDemirelli E., Ögreden E., Bayraktar C., Tosun A., Oguz U. (Giresun, Turkey)
12 5th Baltic meeting in conjunction with the EAU
Poster session 5
Saturday, 26 May 2018
14.15 - 15.30 Urothelial tumours and BPO Chairs: A. Minich, Minsk (BY) TBCBeta Room 1
69 Assessment of haematuriaKannan S., Bhuvanagiri A., Gundupalli D., Fegredo D., Nadeem T., Allen B., Robinson B., Tivey A., Edge E., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom)
70 Gender-related differences in clinicopathological features of patients with upper urinary tract urothelial carcinomaKaczmarek K., Leminski A., Gajewska D., Gołab A., Soczawa M., Słojewski M. (Szczecin, Poland)
71 Men have an increased incidence of high stage bladder cancerGajewska D., Kaczmarek K., Poletajew S., Krajewski W., Sondka-Migdalska J., Borowik M., Buraczynski P., Dziegała M., Łykowski M., Przudzik M., Bar K., Jabłonowski Z., Roslan M., Zdrojowy R., Radziszewski P., Słojewski M. (Szczecin, Warsaw, Wrocław,Łódz,Olsztyn,Lublin, Poland)
72 Evaluation of second-look transurethral resection in restaging of patients with T1 high-grade bladder cancerChaker K., Ben Rhouma S., Sellami A., Ben Chehida M.A., Nouira Y. (Tunis, Tunisia)
73 Prognostic significance of pathological substaging of T1 urothelial transitionalcell carcinomaNabebina T.I., Rolevich A.I., Mokhort A., Dubrouski A.Ch., Krasny S.A. (Minsk, Belarus)
74 A candidate antineoplastic herbal agent in bladder cancer: Ankaferd the bloodstopperSari H., Celik S., Aktas S., Bozkurt O., Yorukoglu K., Celebi I., Mungan M.U. (Izmir, Turkey)
75 Pyuria can be prognostic marker for poor oncological outcome prior TUR-BTGajewska D., Kaczmarek K., Poletajew S., Krajewski W., Sondka-Migdalska J., Borowik M., Buraczynski P., Dziegała M., Łykowski M., Przudzik M., Radziszewski P., Bar K., Jabłonowski Z., Roslan M., Zdrojowy R., Słojewski M. (Szczecin, Warsaw, Wrocław, Łódz, Olsztyn, Lublin, Poland)
76 Correlation between perioperative parameters and long-term survival after radical cystectomyRyndzin A., Zaitseva L., Poluyanchik A., Minich A., Krasny S. (Minsk district, Lesnoy, Belarus)
77 Analysis of the perioperative and oncological outcome of 164 cases of laparoscopic radical cystectomy: A single center experienceSemenov D., Nosov A., Djalilov I., Petrov S., Reva S. (S-Petersburg, Russia)
78 Laparoscopic radical cystectomy in the elderly: Analysis of a single centerSemenov D., Nosov A., Djalilov I., Petrov S., Reva S. (S-Petersburg, Russia)
79 A comparison of EORTC and CUETO risk tables in terms of the prediction of recurrence and progression in all non-muscle-invasive bladder cancer patientsDalkilic A., Bayar G., Kilinc M.F. (Istanbul,Ankara, Turkey)
80 Sexual life outcomes after radical cystectomy with external urinary derivationChaker K., Sellami A., Ouanes Y., Ben Chehida M.A., Abid K., Ben Rhouma S., Nouira Y. (Tunis, Tunisia)
81 Prostate resection speed in TURP - how determining is this for patients and how appropriate as a measure for assessing trainees?Donati-Bourne J.F., Nour S.S., Delves G. (Burton-on-Trent, United Kingdom)
82 The most important factor in prostate biopsy decision of patients with high prostate volume (over 80 cc) is PSA densityEdiz C., Yilmaz Ö., Akan S., Temel M.C., Ates F., Cimen S. (Istanbul,Malatya, Turkey)
83 Does the dutasteride has any cardioprotective effect in elderly men? Prospective - randomised - non-placebo controlled studyOguz U., Karagöz A., Tosun A., Demirelli E., Usta M., Ögreden E., Karagöz E., Karadayi M., Köseoglu M.H., Baser B., Yalçın O. (Giresun, Turkey)
84 Comparison of hemostatic methods for transvesical prostatectomy and large prostatic adenomaAdaschik V., Strotsky A., Buldyk Y., Gavrusev A. (Minsk, Belarus)
1325-26 May 2018
Poster session 6
Saturday, 26 May 2018
14.15 - 15.30 Infections and paediatrics Chairs: V. Lietuvietis, Riga (LV) TBCBeta Room 2
85 Retrospective evaluation of patients’ semen culture with CPPS/CP like symptomsMarkevicius M. (Klaipeda, Lithuania)
86 Antibiotic resistance E. coli in urological hospitalsRudenka D., Scobeus I.A., Strotsky A.V., Rahuzin A. (Minsk, Belarus)
87 Antibiotic resistance in patients with complicated urinary tract infections and acute pyelonephritis in Pauls Stradins Clinical University HospitalPogodina V., Vjaters E. (Riga, Latvia)
88 Outcome and clinical characteristics of urosepsis patients in a tertiary hospital intensive care unitFreimanis A., Laizans S., Silina S., Redmanis L., Lietuvietis V. (Riga, Latvia)
89 Hospital admission following transrectal ultrasound scan and prostate biopsyBhuvanagiri A.K., Kannan S., William S.M.W., Gundupalli D., Hassan U., Fegredo D., Allen B., Robinson B., Arshad S., Nadeem T., Tivey A., Edge E., Thangavelu M., Ahiaku E.K, Alexandrou K. (Bangor, United Kingdom)
90 Drug resistance of Trichomonas vaginalis in patients with recurrent urethroprostatitisGavrusev A., Strotsky A., Malashchitsky D., Rubanik L. (Minsk, Belarus)
91 Surgical correction of combined ureteral obstructions in childrenYoushko E., Strotsky A. (Minsk, Belarus)
92 The relationship between inhalant allergens and nocturnal enuresis: A prospective and controlled trialYavuz A., Yildirim O., Bayar G., Uslu B., Bayar G., Kilinc M.F. (Hatay,Istanbul,Ankara, Turkey)
93 The relationship between nocturnal enuresis and spina bifida occulta: A prospective controlled trialYavuz A., Bayar G., Kilinc M.F., Sariogullari U. (Hatay,Istanbul,Ankara, Turkey)
94 Can we predict the need for surgery for a communicating hydrocele in infants: Prospective cohort studyBayar G., Yavuz A., Kilinc M.F., Dalkilic A., Horasanli K. (Istanbul,Hatay,Ankara, Turkey)
14 5th Baltic meeting in conjunction with the EAU
Do not missthe AwardSession!Prestigious awards for Best Poster Presentations and Young Urologist Competitors will be handed out on the last day of the meeting
• The awards will be presented at the end of the meeting by Dr. Peteris Vaganovs.
• The award winners will be selected on-site by the chairmen of the poster sessions.
• The award-winning posters will be displayed in a specifically designated area at the Annual EAU Congress
• The award winners will be invited to present their poster at the 34th Annual EAU congress in Barcelona, 15-19 March 2019 the duration of the congress.
Industry sponsored
Saturday, 26 May 201816.30 hrsPlenary Room (Alfa room)
BC-ID
-PRO
-1
5th Baltic Meeting in conjunction with the (Baltic18)25 – 26 May 2018, Riga, Latvia
Session sponsored by Berlin-Chemie/Menarini
Friday, 25 May 2018, 12.00 – 13.00
ERECTILE DYSFUNCTION AND LUTS
Chair: E. Vjaters, Riga (LV)
Overactive Bladder, LUTS and Erectile DysfunctionC.R. Chapple, Sheffield (GB) Secrets in the use of PDE5i: Lessons from the everyday clinical practiceD. Hatzichristou, Thessaloniki (GR)
followed by
Case discussionK. Miculis, Riga (LV) and R. Okas, Tallinn (EE)
Venue: Radisson Blu Hotel Latvija Elizabetes 55, LV-1010 Riga, Latvia
INVITATIONJanssen Satellite Symposium at the 5th Baltic
Meeting in conjunction with the EAU
Treatment landscape of metastatic prostate cancer:
are there any changes?Venue
Radisson Blu Hotel Latvija26th May, 2018
9:45–10:45Moderated by Dr. Peteris Vaganovs (LV)
Welcome and IntroductionDr. Peteris Vaganovs
Treatment landscape of metastatic prostate cancer: are there any changes?Prof. Nicolas Mottet (FR)
Discussion, Q&A (All)
PHBL/ZYT/0518/0001
The EAU is very grateful for the support of thefollowing contributors:
MAIN SPONSORS
SPONSORS
ASTELLAS
BIONORICA
BRAUN
IPSEN
NOVARTIS
OLYMPUS
PHARMA SWISS
SCANMED
WOLF
Contributors
18
An application hasbeen made to theEACCME® for CMEaccreditation ofthis event
www.baltic19.org
Call for Abstracts Deadline 1 April 2019
BALTIC196th Baltic Meeting in conjunction with the EAU
24-25 May 2019, Tallinn, Estonia
Cutting-edge Science at Europe’s largest Urology Congress
34th Annual EAU Congress
Abstract submission deadline: 1 November 2018
www.eau19.org
